Mobile electrocardiogram (ECG) devices have witnessed significant traction in recent years owing to advantages such as portability, convenience and quick diagnosis. These devices enable recording of heart activity through sensors placed on the chest and transmit the ECG readings to a smartphone or tablet via Bluetooth. Growing prevalence of cardiovascular diseases and increasing health awareness among consumers have prompted a rise in self-monitoring using mobile ECG devices. Advancements in wireless technology and miniaturization of components have enabled manufacturing of compact and affordable mobile ECG solutions. With effective integration with medical records and clinical decision support systems, mobile ECG devices are gradually transforming point-of-care cardiology diagnostics.
Market Dynamics:
Global mobile ECG devices market growth is driven by factors such as increasing geriatric population vulnerable to cardiac issues, rising healthcare expenditure in developing nations, growing popularity of telehealth and remote patient monitoring, and technological upgrades in wireless connectivity. However, data privacy concerns, lack of reimbursements and high costs of advanced devices are some challenges restraining the market growth. Emerging economies offer lucrative opportunities with their gigantic patient pools and improved access to healthcare services. Moreover, integration of artificial intelligence capabilities for automatic arrhythmia detection is gaining momentum in mobile ECG devices.
Key features of the study:
- This report provides in-depth analysis of the global mobile ECG devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global mobile ECG devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AliveCor, Beurer UK Ltd., Borsam Biomedical Instrument, GE Healthcare, Medtronic, iRhythm Technologies, Inc., Koninklijke Philips N.V., Emay, Dr Trust, Omron, Nihon Kohden Corporation, InfoBionic, BHA MEDICAL, Lepu Medical Technology(Beijing) Co.,Ltd. And Panasonic Industry
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global mobile ECG devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mobile ECG devices market
Detailed Segmentation:
- Global Mobile ECG devices Market, By Modality
- Global Mobile ECG devices Market, By End User
- Hospitals
- Diagnostic Centers
- Ambulatory Care
- Homecare
- Others
- Global Mobile ECG devices Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Top Companies in the Global Mobile ECG devices Market:
- AliveCor.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Beurer UK Ltd.
- Borsam Biomedical Instrument
- GE Healthcare
- Medtronic
- iRhythm Technologies, Inc.,
- Koninklijke Philips N.V.
- Emay
- Dr Trust
- Omron
- Nihon Kohden Corporation
- InfoBionic
- BHA MEDICAL
- Lepu Medical Technology(Beijing)Co.,Ltd.
- Panasonic Industry